A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Our Community Bookmark and Share

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
Contact us at diversityandinclusion@coh.org for more information.

Our Community

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
Contact us at diversityandinclusion@coh.org for more information.
We're a community of people characterized by our diversity of thought, background and approach.
 
We have career opportunities in nursing, research, allied health, business support and many other areas.
 
City of Hope employees enjoy excellent benefits and an environment that inspires wellness.
 
In addition to our main campus in Duarte, CA, we have several locations throughout the Los Angeles vicinity.
 
Current employees and external candidates are invited to explore our career opportunities.
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...
  • Cancer cells are masters of survival. Despite excessive damage to their most basic workings and the constant vigilance of the body’s immune system, they manage to persevere. Much of this extraordinary ability to survive falls under the control of proteins bearing the name STAT, short for signal transducer and a...
  • One person receives the breast cancer diagnosis, but the cancer affects the entire family. Couples, in particular, can find the diagnosis and treatment challenging, especially if they have traditional male/female communication styles. “Though every individual is unique, men and women often respond differently d...
  • Here’s a statistic you’ll hear and read frequently over the next month: One in eight women born in the United States will develop breast cancer at some point in her lifetime. Although this statement is accurate, based on breast cancer incidence rates in 2013, it’s often misunderstood. Leslie Bernstein, Ph.D., d...
  • This time of year, how can anyone not think pink? Through the power of pastel packaging, October has been etched permanently into the American public’s consciousness as Breast Cancer Awareness Month. The color pink is now synonymous with breast cancer. Suffice to say, awareness has been raised. Now itR...
  •   Breast cancer facts: About one in eight women in the U.S. will develop invasive breast cancer during her lifetime. Breast cancer is the most common cancer in American women, behind skin cancer. An estimated 232,670 new cases of invasive breast cancer will be diagnosed in U.S. women this year. Two of thre...
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....